About this event
Starting 1 October 2024, Pharmac will begin funding continuous glucose monitoring (CGM) devices, insulin pumps, and insulin pump consumables for individuals with type 1 diabetes and other specific forms of diabetes. This is a game-changer for diabetes management in New Zealand. Learn more.
This funding includes the #1 CGM worldwide, used by more than 6 million people*: FreeStyle Libre.
Join our webinar to learn more about the Pharmac CGM funding scheme, as well as to learn more about the two FreeStyle Libre products that will be 100% funded through this scheme:
- The FreeStyle Libre 2 sensor
- The FreeStyle Libre 3 Plus sensor
Speakers:
- Jessica Montgomery, Territory Manager for Mediray New Zealand
- Gary Rooke, Training Manager, Abbott Diabetes Care Australia & New Zealand
___________
*Data based on the number of users worldwide for FreeStyle Libre family of personal CGMs compared to the number of users for other leading personal CGM brands and based on CGM sales dollars compared to other leading personal CGM brands.
ADC-99211 V1.0
Hosted by
-
Team member
Bec, AbbottT
-
Team member
FreeStyle Libre TeamFL T
-
Team member
Jacob AbbottJA T
-
Team member
James AbbottJA T
-
Team member
Jessica AbbottJA T
-
Team member
Cath Abbott Abbott Diabetes CareCA T
-
Team member
Jess Mediray MedirayT
-
Team member
Gary Abbott Training Manager @ Abbott Aus Pty ltdGA T
-
Team member
Kanchiny AbbottKA T
-
Team member
Victoria AbbottVA T
Abbott
Abbott, Diabetes CareWe’re dedicated to helping people live more fully, in everything we do. We’re creating the future of healthcare through life-changing technologies and products that make you healthier and stronger, quickly identify when you have a medical need, and treat conditions to help get back to what you love.
